222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016

Collaborators, Affiliations

222nd ENMC workshop participants:
Antonio Atalaia⁶, Pavel Balabanov⁷, Guillaume Bassez⁸, Matthias Boentert⁹, Jeanette Charlton¹⁰, Baziel van Engelen¹¹, Cynthia Gagnon¹², Alain Geille¹³, Chad Heatwole¹⁴, Arend Heerschap¹¹, Marie Kierkegaard¹⁵, Cornelia Kornblum¹⁶, Christopher Lindberg¹⁷, Hanns Lochmüller¹⁸, Giovanni Meola¹⁹, Laurence Mignon²⁰, Darren Monckton²¹, John Porter²², Valeria Sansone¹⁹, Benedikt Schoser²³, Vidosava Stojanović²⁴, Rachel Thompson⁶, Shaun Treweek²⁵, John Vissing²⁶, Libby Wood⁶

¹ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK. Electronic address: libby.wood@ncl.ac.uk.
² Neuromuscular Reference Center, Henri Mondor, L'assitance Publique - Hopitaux de Paris, France.
³ Department of Neurology, Radboud University Medical Centre, Netherlands.
⁴ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK.
⁵ Friedrich-Baur-Institute, Department of Neurology University Clinics Ludwig-Maximilians-University of Munich, Germany.
⁶ Newcastle, UK.
⁷ European Medicines Agency, UK.
⁸ Paris, France.
⁹ Münster, Germany.
¹⁰ Patient and family representative, UK.
¹¹ Nijmegen, The Netherlands.
¹² Quebec, Canada.
¹³ Patient and family representative, France.
¹⁴ Rochester, USA.
¹⁵ Stockholm, Sweden.
¹⁶ Bonn, Germany.
¹⁷ Gothenburg, Sweden.
¹⁸ Newcastle University, UK.
¹⁹ Milan, Italy.
²⁰ IONIS Pharmaceuticals, USA.
²¹ Glasgow, UK.
²² Myotonic Dystrophy Foundation, USA.
²³ Munich, Germany.
²⁴ Belgrade, Serbia.
²⁵ Aberdeen, UK.
²⁶ Copenhagen, Denmark.

Libby Wood et al. Neuromuscul Disord. 2018 May.

. 2018 May;28(5):463-469.

doi: 10.1016/j.nmd.2018.02.003. Epub 2018 Feb 12.

222nd ENMC workshop participants:
Antonio Atalaia⁶, Pavel Balabanov⁷, Guillaume Bassez⁸, Matthias Boentert⁹, Jeanette Charlton¹⁰, Baziel van Engelen¹¹, Cynthia Gagnon¹², Alain Geille¹³, Chad Heatwole¹⁴, Arend Heerschap¹¹, Marie Kierkegaard¹⁵, Cornelia Kornblum¹⁶, Christopher Lindberg¹⁷, Hanns Lochmüller¹⁸, Giovanni Meola¹⁹, Laurence Mignon²⁰, Darren Monckton²¹, John Porter²², Valeria Sansone¹⁹, Benedikt Schoser²³, Vidosava Stojanović²⁴, Rachel Thompson⁶, Shaun Treweek²⁵, John Vissing²⁶, Libby Wood⁶

¹ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK. Electronic address: libby.wood@ncl.ac.uk.
² Neuromuscular Reference Center, Henri Mondor, L'assitance Publique - Hopitaux de Paris, France.
³ Department of Neurology, Radboud University Medical Centre, Netherlands.
⁴ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK.
⁵ Friedrich-Baur-Institute, Department of Neurology University Clinics Ludwig-Maximilians-University of Munich, Germany.
⁶ Newcastle, UK.
⁷ European Medicines Agency, UK.
⁸ Paris, France.
⁹ Münster, Germany.
¹⁰ Patient and family representative, UK.
¹¹ Nijmegen, The Netherlands.
¹² Quebec, Canada.
¹³ Patient and family representative, France.
¹⁴ Rochester, USA.
¹⁵ Stockholm, Sweden.
¹⁶ Bonn, Germany.
¹⁷ Gothenburg, Sweden.
¹⁸ Newcastle University, UK.
¹⁹ Milan, Italy.
²⁰ IONIS Pharmaceuticals, USA.
²¹ Glasgow, UK.
²² Myotonic Dystrophy Foundation, USA.
²³ Munich, Germany.
²⁴ Belgrade, Serbia.
²⁵ Aberdeen, UK.
²⁶ Copenhagen, Denmark.

No abstract available

Publication types